Amphastar Pharmaceuticals AMPH Income taxes payable – long-term
Income taxes payable – long-term at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccruedIncomeTaxesNoncurrent.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's income taxes payable – long-term.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's income taxes payable – long-term?
- Amphastar Pharmaceuticals (AMPH) reported income taxes payable – long-term of $5.93M in Q1 2026.
- How has Amphastar Pharmaceuticals's income taxes payable – long-term changed year-over-year?
- Amphastar Pharmaceuticals's income taxes payable – long-term decreased by 14.8% year-over-year, from $6.96M to $5.93M.
- What is the long-term trend for Amphastar Pharmaceuticals's income taxes payable – long-term?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's income taxes payable – long-term has grown at a 4.7% compound annual growth rate (CAGR), from $4.71M to $5.93M.